515
Views
25
CrossRef citations to date
0
Altmetric
Pages 1774-1782 | Published online: 01 Nov 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Pratima Nangia-Makker, Tirza Raz, Larry Tait, Malathy P.V. Shekhar, Hong Li, Vitaly Balan, Hemanckur Makker, Rafael Fridman, Krishnarao Maddipati & Avraham Raz. (2013) Ocimum gratissimum retards breast cancer growth and progression and is a natural inhibitor of matrix metalloproteases. Cancer Biology & Therapy 14:5, pages 417-427.
Read now
Kelly K. Haagenson, Larry Tait, Juan Wang, Malathy P. Shekhar, Lisa Polin, Wei Chen & Gen Sheng Wu. (2012) Cullin-3 protein expression levels correlate with breast cancer progression. Cancer Biology & Therapy 13:11, pages 1042-1046.
Read now

Articles from other publishers (23)

Kosuke Okada, Quentin Cassar, Hironaru Murakami, Gaëtan MacGrogan, Jean-Paul Guillet, Patrick Mounaix, Masayoshi Tonouchi & Kazunori Serita. (2022) Scanning point terahertz source microscopy of unstained comedo ductal carcinoma in situ. Optics Continuum 1:3, pages 527.
Crossref
Julia Samson, Magdalina Derlipanska, Oza Zaheed & Kellie Dean. (2021) Molecular and cellular characterization of two patient-derived ductal carcinoma in situ (DCIS) cell lines, ETCC-006 and ETCC-010. BMC Cancer 21:1.
Crossref
Eric Parigoris, Soojung Lee, David Mertz, Madeleine Turner, Amy Y. Liu, Jason Sentosa, Sabra Djomehri, Hao Chen Chang, Kathryn Luker, Gary Luker, Celina G. Kleer & Shuichi Takayama. (2020) Cancer Cell Invasion of Mammary Organoids with Basal‐In Phenotype. Advanced Healthcare Materials 10:4, pages 2000810.
Crossref
Damilohun Samuel Metibemu, Oluseyi Adeboye Akinloye, Adio Jamiu Akamo, Jude Ogechukwu Okoye, David Ajiboye Ojo, Eric Morifi & Idowu Olaposi Omotuyi. (2021) VEGFR-2 kinase domain inhibition as a scaffold for anti-angiogenesis: Validation of the anti-angiogenic effects of carotenoids from Spondias mombin in DMBA model of breast carcinoma in Wistar rats. Toxicology Reports 8, pages 489-498.
Crossref
Netta Vidavsky, Jennie A. M. R. Kunitake, Maria Elena Diaz-Rubio, Aaron E. Chiou, Hyun-Chae Loh, Sheng Zhang, Admir Masic, Claudia Fischbach & Lara A. Estroff. (2019) Mapping and Profiling Lipid Distribution in a 3D Model of Breast Cancer Progression. ACS Central Science 5:5, pages 768-780.
Crossref
Arantzazu Zubeldia-Plazaola, Leire Recalde-Percaz, Núria Moragas, Mireia Alcaraz, Xieng Chen, Mario Mancino, Patricia Fernández-Nogueira, Miquel Prats de Puig, Flavia Guzman, Aleix Noguera-Castells, Anna López-Plana, Estel Enreig, Neus Carbó, Vanessa Almendro, Pedro Gascón, Paloma Bragado & Gemma Fuster. (2018) Glucocorticoids promote transition of ductal carcinoma in situ to invasive ductal carcinoma by inducing myoepithelial cell apoptosis. Breast Cancer Research 20:1.
Crossref
Yueling Jin, Xiuying Huang, Yanfei Li, Xuemei Li & Zhensheng Dai. (2017) Clinical Pathological Analysis in 104 Ductal Breast Cancer Cases. Journal of Biosciences and Medicines 05:12, pages 37-43.
Crossref
Brittany Haynes, Yanhua Zhang, Fangchao Liu, Jing Li, Sarah Petit, Hend Kothayer, Xun Bao, Andrew D. Westwell, Guangzhao Mao & Malathy P.V. Shekhar. (2016) Gold nanoparticle conjugated Rad6 inhibitor induces cell death in triple negative breast cancer cells by inducing mitochondrial dysfunction and PARP-1 hyperactivation: Synthesis and characterization. Nanomedicine: Nanotechnology, Biology and Medicine 12:3, pages 745-757.
Crossref
Tanya D. Russell, Sonali Jindal, Samiat Agunbiade, Dexiang Gao, Megan Troxell, Virginia F. Borges & Pepper Schedin. (2015) Myoepithelial Cell Differentiation Markers in Ductal Carcinoma in Situ Progression. The American Journal of Pathology 185:11, pages 3076-3089.
Crossref
K C Scribner, F Behbod & W W Porter. (2012) Regulation of DCIS to invasive breast cancer progression by Singleminded-2s (SIM2s). Oncogene 32:21, pages 2631-2639.
Crossref
Ashwani Khurana, Deok Jung-Beom, Xiaoping He, Sung-Hoon Kim, Robert C. Busby, Laura Lorenzon, Massimo Villa, Alfonso Baldi, Julian Molina, Matthew P. Goetz & Viji Shridhar. (2013) Matrix detachment and proteasomal inhibitors diminish Sulf-2 expression in breast cancer cell lines and mouse xenografts. Clinical & Experimental Metastasis 30:4, pages 407-415.
Crossref
Malathy P.V. ShekharIkuko KatoPratima Nangia-MakkerLarry Tait. (2013) Comedo-DCIS is a precursor lesion for basal-like breast carcinoma: identification of a novel p63/Her2/neu expressing subgroup. Oncotarget 4:2, pages 231-241.
Crossref
Nandita Barnabas & Dalia Cohen. (2013) Phenotypic and Molecular Characterization of MCF10DCIS and SUM Breast Cancer Cell Lines. International Journal of Breast Cancer 2013, pages 1-16.
Crossref
Malathy P. V. Shekhar. 2013. Molecular Mechanisms of Tumor Cell Resistance to Chemotherapy. Molecular Mechanisms of Tumor Cell Resistance to Chemotherapy 245 258 .
John L McElwee, Sunish Mohanan, Obi L Griffith, Heike C Breuer, Lynne J Anguish, Brian D Cherrington, Ashley M Palmer, Louise R Howe, Venkataraman Subramanian, Corey P Causey, Paul R Thompson, Joe W Gray & Scott A Coonrod. (2012) Identification of PADI2 as a potential breast cancer biomarker and therapeutic target. BMC Cancer 12:1.
Crossref
Raghav K. Chhetri, Zachary F. Phillips, Melissa A. Troester & Amy L. Oldenburg. (2012) Longitudinal Study of Mammary Epithelial and Fibroblast Co-Cultures Using Optical Coherence Tomography Reveals Morphological Hallmarks of Pre-Malignancy. PLoS ONE 7:11, pages e49148.
Crossref
Ashwani Khurana, Hiedi McKean, Hyunseok Kim, Sung-Hoon Kim, Jacie Mcguire, Lewis R Roberts, Matthew P Goetz & Viji Shridhar. (2012) Silencing of HSulf-2 expression in MCF10DCIS.com cells attenuate ductal carcinoma in situ progression to invasive ductal carcinoma in vivo. Breast Cancer Research 14:2.
Crossref
Michal Zikan, Jan Bohm, David Pavlista & David Cibula. (2011) Comparative analysis of loss of heterozygosity and expression profi le in normal tissue, DCIS and invasive breast cancer. Clinical and Translational Oncology 13:9, pages 652-655.
Crossref
Brigitte Gerard, Larry Tait, Pratima Nangia-Makker & Malathy P V Shekhar. (2011) Rad6B acts downstream of Wnt signaling to stabilize ?-catenin: Implications for a novel Wnt/?-catenin target. Journal of Molecular Signaling 6, pages 6.
Crossref
Pratima Nangia‐Makker, Yi Wang, Tirza Raz, Larry Tait, Vitaly Balan, Victor Hogan & Avraham Raz. (2010) Cleavage of galectin‐3 by matrix metalloproteases induces angiogenesis in breast cancer. International Journal of Cancer 127:11, pages 2530-2541.
Crossref
M. Sharma, A. H. Beck, J. A. Webster, I. Espinosa, K. Montgomery, S. Varma, M. van de Rijn, K. C. Jensen & R. B. West. (2009) Analysis of stromal signatures in the tumor microenvironment of ductal carcinoma in situ. Breast Cancer Research and Treatment 123:2, pages 397-404.
Crossref
Christine J. Ye, Joshua B. Stevens, Guo Liu, Steven W. Bremer, Aruna S. Jaiswal, Karen J. Ye, Ming-Fong Lin, Lesley Lawrenson, Wayne D. Lancaster, Markku Kurkinen, Joshua D. Liao, C. Gary Gairola, Malathy P.V. Shekhar, Satya Narayan, Fred R. Miller & Henry H.Q. Heng. (2009) Genome based cell population heterogeneity promotes tumorigenicity: The evolutionary mechanism of cancer. Journal of Cellular Physiology 219:2, pages 288-300.
Crossref
Alexandra C. Silveira, Douglas R. Hurst, Kedar S. Vaidya, Donald E. Ayer & Danny R. Welch. (2009) Over-expression of the BRMS1 family member SUDS3 does not suppress metastasis of human cancer cells. Cancer Letters 276:1, pages 32-37.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.